Buy Or Sell Opportunity • Apr 22
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.6% to CN¥29.18. The fair value is estimated to be CN¥38.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 26%. Annuncio • Apr 22
China Catalyst Holding Co., Ltd., Annual General Meeting, May 13, 2026 China Catalyst Holding Co., Ltd., Annual General Meeting, May 13, 2026, at 14:00 China Standard Time. Location: The Company's Lecture Hall, Dalian, Liaoning China Annuncio • Mar 30
China Catalyst Holding Co., Ltd. to Report Q1, 2026 Results on Apr 22, 2026 China Catalyst Holding Co., Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026 Price Target Changed • Mar 08
Price target decreased by 7.4% to CN¥25.00 Down from CN¥27.00, the current price target is provided by 1 analyst. New target price is 17% below last closing price of CN¥30.20. Stock is up 14% over the past year. The company is forecast to post earnings per share of CN¥1.39 for next year compared to CN¥1.20 last year. Annuncio • Dec 26
China Catalyst Holding Co., Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026 China Catalyst Holding Co., Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.26 (vs CN¥0.099 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.26 (up from CN¥0.099 in 3Q 2024). Revenue: CN¥209.4m (up 65% from 3Q 2024). Net income: CN¥46.2m (up 168% from 3Q 2024). Profit margin: 22% (up from 14% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Annuncio • Sep 30
China Catalyst Holding Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 China Catalyst Holding Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Reported Earnings • Aug 08
Second quarter 2025 earnings released: EPS: CN¥0.49 (vs CN¥0.35 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.49 (up from CN¥0.35 in 2Q 2024). Revenue: CN¥262.1m (up 33% from 2Q 2024). Net income: CN¥86.1m (up 40% from 2Q 2024). Profit margin: 33% (up from 31% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Annuncio • Jun 30
China Catalyst Holding Co., Ltd. to Report First Half, 2025 Results on Aug 07, 2025 China Catalyst Holding Co., Ltd. announced that they will report first half, 2025 results on Aug 07, 2025 Declared Dividend • Jun 12
Dividend increased to CN¥0.35 Dividend of CN¥0.35 is 75% higher than last year. Ex-date: 16th June 2025 Payment date: 16th June 2025 Dividend yield will be 1.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (40% earnings payout ratio) and cash flows (71% cash payout ratio). The dividend has increased by an average of 15% per year over the past 3 years. However, payments have been volatile during that time. EPS is expected to grow by 23% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 25
First quarter 2025 earnings released: EPS: CN¥0.23 (vs CN¥0.20 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.23 (up from CN¥0.20 in 1Q 2024). Revenue: CN¥199.0m (flat on 1Q 2024). Net income: CN¥40.7m (up 16% from 1Q 2024). Profit margin: 21% (up from 18% in 1Q 2024). Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 5% per year. Annuncio • Apr 25
China Catalyst Holding Co., Ltd., Annual General Meeting, May 16, 2025 China Catalyst Holding Co., Ltd., Annual General Meeting, May 16, 2025, at 14:00 China Standard Time. Location: The Company's Lecture Hall, Dalian, Liaoning China Price Target Changed • Apr 16
Price target increased by 11% to CN¥30.00 Up from CN¥27.00, the current price target is provided by 1 analyst. New target price is 26% above last closing price of CN¥23.86. Stock is up 18% over the past year. The company is forecast to post earnings per share of CN¥1.23 for next year compared to CN¥0.85 last year. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥21.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 30% over the past three years. Annuncio • Mar 28
China Catalyst Holding Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 China Catalyst Holding Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Reported Earnings • Feb 27
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.85 (up from CN¥0.44 in FY 2023). Revenue: CN¥666.6m (up 21% from FY 2023). Net income: CN¥145.7m (up 89% from FY 2023). Profit margin: 22% (up from 14% in FY 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 20%. Earnings per share (EPS) also missed analyst estimates by 14%. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings. Annuncio • Dec 27
China Catalyst Holding Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 China Catalyst Holding Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥23.77, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 16% over the past year. Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.099 (vs CN¥0.025 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.099 (up from CN¥0.025 in 3Q 2023). Revenue: CN¥127.2m (flat on 3Q 2023). Net income: CN¥17.2m (up 324% from 3Q 2023). Profit margin: 14% (up from 3.2% in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Annuncio • Sep 30
China Catalyst Holding Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 China Catalyst Holding Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to CN¥20.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 2.7% over the past year. Major Estimate Revision • Aug 28
Consensus EPS estimates increase by 16% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥856.5m to CN¥924.5m. EPS estimate increased from CN¥0.815 to CN¥0.945 per share. Net income forecast to grow 37% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target of CN¥25.40 unchanged from last update. Share price fell 2.6% to CN¥19.38 over the past week. Reported Earnings • Aug 22
Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.24 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.35 (up from CN¥0.24 in 2Q 2023). Revenue: CN¥197.0m (up 73% from 2Q 2023). Net income: CN¥61.4m (up 65% from 2Q 2023). Profit margin: 31% (down from 33% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Annuncio • Jun 28
China Catalyst Holding Co., Ltd. to Report First Half, 2024 Results on Aug 22, 2024 China Catalyst Holding Co., Ltd. announced that they will report first half, 2024 results on Aug 22, 2024 Major Estimate Revision • Apr 25
Consensus EPS estimates fall by 14%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥730.0m to CN¥738.0m. EPS estimate fell from CN¥0.895 to CN¥0.77 per share. Net income forecast to grow 39% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥27.50 unchanged from last update. Share price rose 4.2% to CN¥20.94 over the past week. Reported Earnings • Apr 24
First quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.01 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.20 (up from CN¥0.01 in 1Q 2023). Revenue: CN¥198.9m (up 61% from 1Q 2023). Net income: CN¥35.1m (up CN¥33.0m from 1Q 2023). Profit margin: 18% (up from 1.7% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Annuncio • Apr 23
China Catalyst Holding Co., Ltd., Annual General Meeting, May 16, 2024 China Catalyst Holding Co., Ltd., Annual General Meeting, May 16, 2024, at 14:30 China Standard Time. Location: The Company's Lecture Hall, Dalian, Liaoning China Annuncio • Mar 30
China Catalyst Holding Co., Ltd. to Report Q1, 2024 Results on Apr 23, 2024 China Catalyst Holding Co., Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024 Reported Earnings • Feb 28
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: CN¥0.44 (down from CN¥0.90 in FY 2022). Revenue: CN¥549.9m (down 19% from FY 2022). Net income: CN¥76.9m (down 49% from FY 2022). Profit margin: 14% (down from 22% in FY 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 32%. Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥13.34, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 64% over the past year. New Risk • Nov 03
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 39% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Major Estimate Revision • Aug 30
Consensus revenue estimates fall by 26% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥922.0m to CN¥685.0m. EPS estimate fell from CN¥1.14 to CN¥0.85 per share. Net income forecast to grow 50% next year vs 63% growth forecast for Chemicals industry in China. Consensus price target down from CN¥45.00 to CN¥41.00. Share price rose 13% to CN¥22.91 over the past week. Price Target Changed • Aug 25
Price target decreased by 8.9% to CN¥41.00 Down from CN¥45.00, the current price target is an average from 2 analysts. New target price is 99% above last closing price of CN¥20.59. Stock is down 37% over the past year. The company is forecast to post earnings per share of CN¥0.85 for next year compared to CN¥0.90 last year. Reported Earnings • Aug 24
Second quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.24 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.24. Revenue: CN¥113.7m (down 24% from 2Q 2022). Net income: CN¥37.2m (down 12% from 2Q 2022). Profit margin: 33% (up from 28% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 53% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Annuncio • Aug 23
China Catalyst Holding Co., Ltd. (SHSE:688267) announces an Equity Buyback for CNY 60 million worth of its shares. China Catalyst Holding Co., Ltd. (SHSE:688267) announces a share repurchase program. Under the program, the company will repurchase up to CNY 60 million worth of its shares. The repurchase program is valid for 12 months. Annuncio • Jun 28
China Catalyst Holding Co., Ltd. to Report First Half, 2023 Results on Aug 24, 2023 China Catalyst Holding Co., Ltd. announced that they will report first half, 2023 results on Aug 24, 2023 Reported Earnings • Apr 28
First quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.23 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.01 (down from CN¥0.23 in 1Q 2022). Revenue: CN¥123.4m (down 31% from 1Q 2022). Net income: CN¥2.05m (down 94% from 1Q 2022). Profit margin: 1.7% (down from 19% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.061 (vs CN¥0.23 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.061 (down from CN¥0.23 in 3Q 2021). Revenue: CN¥80.0m (down 28% from 3Q 2021). Net income: CN¥10.8m (down 65% from 3Q 2021). Profit margin: 14% (down from 28% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥36.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.23 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.24 (up from CN¥0.23 in 2Q 2021). Revenue: CN¥150.1m (up 36% from 2Q 2021). Net income: CN¥42.2m (up 37% from 2Q 2021). Profit margin: 28% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 77%, compared to a 33% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • May 24
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥33.30, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 17x in the Chemicals industry in China. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥30.21, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 17x in the Chemicals industry in China. Reported Earnings • Feb 27
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CN¥1.00 (up from CN¥0.69 in FY 2020). Revenue: CN¥560.0m (up 38% from FY 2020). Net income: CN¥132.0m (up 44% from FY 2020). Profit margin: 24% (in line with FY 2020). Revenue was in line with analyst estimates.